Understanding the BMI requirements for GLP-1 is essential before starting this process
Heralded as a major liberator for women and sexual freedom, the pill turned out to be a double-edged sword
Trumps healthcare team rejected a last-minute proposal from the Biden administration to have Medicare and Medicaid cover GLP-1 medications for weight loss
10.1111/dom.13111 [Google Scholar] 33.Alimajstorovic Z, Mitchell JL, Yiangou A et al (2023) Determining the role of novel metabolic pathways in driving intracranial pressure reduction after weight loss
it connects the dots between injections, nutrition, side effects, and progress
Glucagon-like peptide-1 (GLP-1) agonists, originally developed to manage type 2 diabetes, are now used to treat obesity due to their metabolic effects (6)